Enanta Stumbles In Trying To Show Better FXR Agonist Profile In NASH

 
• By Joseph Haas
  
Blood sample with requisition form for liver enzyme (AST, ALT) test - Image
Enanta's NASH drug lowered ALT levels, but the fuller picture is unclear
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D